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Mimicking the function of kidney, lung, liver or pancreas 
Artificial organs with 
natural intelligence 
Before entering national service in Greece, in 1985 Dimitrios Stamatialis, who was 
27 at the time, travelled to Twente to take up a postdoc fellowship in membrane 
technology at the UT. After the turn of the century, he returned here to resume his 
academic career. Since 2013, Stamatialis has been Professor of Biomeical 
Membranes and (bio)artificial organs at the UT. 
 
Development of bioartificial organs is how Stamatialis describes his research at the UT. He has 
also been teaching Physical Chemistry to students of Biomedical Engineering for years: 
'I teach Bachelor students how to apply the principles of physics and chemistry to understanding 
life. With Master students, those principles are applied more specifically to my research into 
bioartificial organs that can mimic the function of a disfunctional kidney, lung, liver or pancreas.'  
  
Difficult 
There is an urgent need to improve the mechanics of artificial kidneys, according to Stamatialis. 
End stage renal disease (ESRD) is an increasing global health problem with an annual growth 
rate of 7-8%. Worldwide there are around 2.5 million patients. The majority of them, 
approximately 80%, are treated by hemodialysis, which is mainly performed in specialised 
dialysis centers. In the Netherlands, there are approximately 40,000 kidney patients from whom 
around 12.000 patients require renal replacement therapy and 6,500 patients are dialyzed. 
Dialysis is not a cure, but is a strenuous, expensive treatment (it costs approximately 90,000 
euros per patient per year), while it can achieve only 15-20% of the removal function of the 
kidneys. 
  
Bearable 
The accumulation of toxins significantly increases the risk of cardiovascular disease, Stamatialis 
knows. His research focuses on improving the most commonly used form of dialysis, 
hemodialysis. 'All of a patient's blood is pumped several times through a filter (artificial kidney), 
which transfers the waste substances from the blood into 120 litres of dialysis liquid flowing 
through the filter in the opposite direction. We are in the process of developing a better filter 
with an extra layer of activated carbon that removes more toxic substances from the blood. At 
the same time, we are looking for ways of making the dialysis system more compact by 
recycling the dialysis liquid so that hemodialysis can be performed at home.' 
   
"There is an urgent need to improve 
the mechanics of artificial kidneys" 
Automatic release 
In addition to the research into a new filter and a more compact system, Stamatialis' group is also 
studying the possibility of adding living kidney cells to the filter: 'Our new filter removes more 
toxins from the blood than the traditional filter, but living kidney cells could remove even more. 
They are intelligent: they know which toxins they should remove and do it more effectively than 
an artificial kidney. 
Going even further, Stamatialis is studying the possibilities of a bioartificial implant for people 
with Type I diabetes: 'the implant with pancreatic cells is placed in contact with the blood 
stream. These pancreatic cells measure the glucose level and administer insulin if needed.' 
  
A better life 
Taking a blood sample and injecting insulin two or three times a day is something that people 
can do in the course of a 'normal' lifestyle, but dialysis for four hours in a hospital three or four 
times a week is scarcely possible any longer. The solutions that Stamatialis is studying will not 
only greatly reduce that burden, but more importantly improve the average condition of patients: 
'Healthy organs work well around the clock. If that only happens periodically, large fluctuations 
occur that affect the patient's condition. If insulin can be automatically administered whenever 
necessary through an implant or if patients can have a more continuous dialysis treatment at 
home during the night, they will have a better quality if life.' 
  
Multi-stage process 
Stamatialis knows there is a long way to go before his ultimate solutions reach the clinic. The 
path of replacing existing extracorporeal artificial organs into implantable bioartificial organs for 
humans will therefore be a multi-stage process: 'We are currently improving the function and 
performance of extra-corporeal artificial organs and investigating the viability of cells, immune 
reactions and the scalability of implantable devices. These future developments are already in 
sight, but in the short term medical practice will benefit most from improving existing methods. 
It is a very urgent issue, because people are still dying every day due to a shortage of donor 
organs. I promise that we will not have to wait much longer for a better and more compact 
dialysis system.' 
 
